Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
RDNT 
RadNet Inc (RDNT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/17/2025: RDNT (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $80.57
1 Year Target Price $80.57
| 5 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 164.7% | Avg. Invested days 73 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/17/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.92B USD | Price to earnings Ratio - | 1Y Target Price 80.57 |
Price to earnings Ratio - | 1Y Target Price 80.57 | ||
Volume (30-day avg) 7 | Beta 1.59 | 52 Weeks Range 45.00 - 93.65 | Updated Date 10/17/2025 |
52 Weeks Range 45.00 - 93.65 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.2 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.78% | Operating Margin (TTM) 7.12% |
Management Effectiveness
Return on Assets (TTM) 1.55% | Return on Equity (TTM) 1.74% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 7032738136 | Price to Sales(TTM) 3.1 |
Enterprise Value 7032738136 | Price to Sales(TTM) 3.1 | ||
Enterprise Value to Revenue 3.69 | Enterprise Value to EBITDA 23.63 | Shares Outstanding 76916062 | Shares Floating 69196766 |
Shares Outstanding 76916062 | Shares Floating 69196766 | ||
Percent Insiders 12.67 | Percent Institutions 94.39 |
Upturn AI SWOT
RadNet Inc
Company Overview
History and Background
RadNet Inc. was founded in 1983. Initially, it focused on outpatient radiology services. Over time, RadNet expanded through acquisitions and organic growth, becoming a large national provider of imaging services.
Core Business Areas
- Outpatient Diagnostic Imaging: Provides a range of diagnostic imaging services, including MRI, CT, PET, mammography, ultrasound, and X-ray.
- Managed Care Services: Contracts with managed care organizations and other payers to provide imaging services to their members.
- Artificial Intelligence: Developing and deploying AI-based solutions to improve imaging accuracy, efficiency, and patient outcomes.
Leadership and Structure
Howard Berger serves as the Chairman, President, and CEO. The company has a typical corporate structure with a board of directors and various executive officers overseeing different departments and regions.
Top Products and Market Share
Key Offerings
- MRI: Magnetic Resonance Imaging. RadNet operates a large fleet of MRI scanners. Market share data not reliably available. Competitors: HCA Healthcare, Tenet Healthcare, SimonMed Imaging.
- CT: Computed Tomography scans. RadNet provides CT scans for a variety of diagnostic purposes. Market share data not reliably available. Competitors: HCA Healthcare, Tenet Healthcare, SimonMed Imaging.
- PET/CT: Positron Emission Tomography/Computed Tomography. Used primarily in oncology. Market share data not reliably available. Competitors: HCA Healthcare, Tenet Healthcare, SimonMed Imaging.
- Mammography: RadNet provides mammography services for breast cancer screening. Market share data not reliably available. Competitors: HCA Healthcare, Tenet Healthcare, SimonMed Imaging.
Market Dynamics
Industry Overview
The diagnostic imaging industry is characterized by increasing demand due to an aging population and technological advancements. Consolidation is ongoing, with large players acquiring smaller practices.
Positioning
RadNet is one of the largest independent providers of outpatient diagnostic imaging services in the US. Its size allows it to negotiate favorable contracts with payers and invest in advanced technology.
Total Addressable Market (TAM)
The TAM for diagnostic imaging in the US is estimated to be over $100 billion. RadNet's positioning as a leading independent provider allows it to capture a significant portion of this market.
Upturn SWOT Analysis
Strengths
- National scale and presence
- Strong relationships with payers
- Investment in advanced technology, including AI
- Experienced management team
Weaknesses
- High debt levels
- Exposure to reimbursement rate pressures
- Dependence on acquisitions for growth
- Geographic concentration in certain markets
Opportunities
- Further consolidation of the imaging market
- Expansion into new geographic markets
- Growth in demand for specialized imaging services
- Development and commercialization of AI-based solutions
Threats
- Changes in healthcare regulations and reimbursement policies
- Increased competition from hospitals and other imaging providers
- Technological obsolescence
- Economic downturn affecting patient volumes
Competitors and Market Share
Key Competitors
- HCA
- THC
- AMN
Competitive Landscape
RadNet's advantages include its national scale, relationships with payers, and investment in technology. Disadvantages include its high debt levels and exposure to reimbursement pressures.
Major Acquisitions
IMG Holding Company, LLC
- Year: 2022
- Acquisition Price (USD millions): 75
- Strategic Rationale: To expand its market presence in the Mid-Atlantic region and leverage IMG's expertise in multi-modality imaging services.
Growth Trajectory and Initiatives
Historical Growth: RadNet has grown significantly through acquisitions and organic growth, but financial data is needed to show exact growth percentage.
Future Projections: Analyst estimates project continued revenue growth, driven by increased demand for imaging services and RadNet's expansion efforts.
Recent Initiatives: Recent initiatives include acquisitions of imaging centers, investment in AI technology, and expansion of managed care contracts.
Summary
RadNet is a leading provider of outpatient diagnostic imaging services, benefiting from its national scale and investments in technology. The company faces challenges including high debt and reimbursement pressures, but is positioned for continued growth through acquisitions and organic expansion. Keeping up with tech such as AI implementation as well as monitoring regulatory changes will be key for the company. The company needs to look out for debt levels.
Peer Comparison
Sources and Disclaimers
Data Sources:
- RadNet Inc. Investor Relations
- SEC Filings
- Industry Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Financial data is based on publicly available information and may not be entirely accurate. Market share data is an estimate. The AI-based rating is based on an algorithm and should not be the sole basis for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About RadNet Inc
Exchange NASDAQ | Headquaters Los Angeles, CA, United States | ||
IPO Launch date 1986-07-01 | Chairman, President & CEO Dr. Howard G. Berger M.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 11000 | Website https://www.radnet.com |
Full time employees 11000 | Website https://www.radnet.com | ||
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.